# 1076193 1317 22 Ketoroloc

DEPARTMENT OF HEALTH SERVICES 
COUNTY OF LOS ANGELES 
 
Medical Control Guideline: DRUG REFERENCE – KETOROLAC Ref. No. 1317.22 
 
 
REVISED: 07-01-24                                 PAGE 1 OF 1 
Classification 
 Nonsteroidal Anti-inflammatory Drug (NSAID) 
 
LA County Prehospital Indications  
Multiple provider impressions: pain management; avoid in cardiac chest pain 
 
Other Common Indications (Not authorized for EMS administration in LA County) 
None 
 
Adult Dose 
15mg (1mL) slow IV/IO push, or 
30mg (2mL) IM 
 
Pediatric Dose  
0.5mg/kg (15mg/mL) slow IV/IO push/IM, dose per MCG 1309 (maximum dose 15mg by any route) 
 
Mechanism of Action 
Reversibly inhibits cyclooxygenase-1 and 2 enzymes, which decreases formation of prostaglandin 
precursors. Inhibits platelet function. Ketorolac has analgesic and anti-inflammatory properties. 
 
Pharmacokinetics 
Onset minutes after IM/IV/IO administration 
 
Contraindications 
Active bleeding 
Active wheezing 
Age < 4 years old or > 65 years old 
Allergy to NSAIDs 
Current anticoagulation therapy 
Current steroid use 
Head or multisystem trauma 
History of upper GI bleeding or peptic ulcer disease 
History of renal disease or kidney transplant 
Known or suspected pregnancy 
Suspected sepsis or septic shock 
 
Interactions 
May enhance the adverse/toxic effect of other NSAIDs and enhance the antiplatelet effect of other agents 
with antiplatelet properties; it may be used if the patient is taking aspirin 
 
Adverse Effects 
Abdominal Pain 
Headache 
Nausea 
 
Prehospital Considerations 
• Review contraindications prior to administration 
• One-time dose in the prehospital setting
